vlog

Object moved to here.

Thyroid Disorders in Children and Adolescents: A Review | Endocrinology | JAMA Pediatrics | vlog

vlog

[Skip to Navigation]
Sign In
1.
Wassner AJ, Brown RS. Congenital hypothyroidism: recent advances.Curr Opin Endocrinol Diabetes Obes. 2015;22(5):407-412.
2.
Rose SR, Brown RS, Foley T, et al; American Academy of Pediatrics; Section on Endocrinology and Committee on Genetics, American Thyroid Association; Public Health Committee, Lawson Wilkins Pediatric Endocrine Society. Update of newborn screening and therapy for congenital hypothyroidism.ʱ徱ٰ. 2006;117(6):2290-2303.
3.
Léger J, Olivieri A, Donaldson M, et al; ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE; Congenital Hypothyroidism Consensus Conference Group. European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism.Horm Res Paediatr. 2014;81(2):80-103.
4.
Rastogi MV, LaFranchi SH. Congenital hypothyroidism.Orphanet J Rare Dis. 2010;5:17.
5.
Binder G, Martin DD, Kanther I, Schwarze CP, Ranke MB. The course of neonatal cholestasis in congenital combined pituitary hormone deficiency.J Pediatr Endocrinol Metab. 2007;20(6):695-702.
6.
Karnsakul W, Sawathiparnich P, Nimkarn S, Likitmaskul S, Santiprabhob J, Aanpreung P. Anterior pituitary hormone effects on hepatic functions in infants with congenital hypopituitarism.Ann Hepatol. 2007;6(2):97-103.
7.
Rhee SS, Braverman LE, Pino S, He X, Pearce EN. High iodine content of Korean seaweed soup: a health risk for lactating women and their infants?ճǾ. 2011;21(8):927-928.
8.
Pesce L, Kopp P. Iodide transport: implications for health and disease.Int J Pediatr Endocrinol. 2014;2014(1):8.
9.
Grüters A, Krude H. Detection and treatment of congenital hypothyroidism.Nat Rev Endocrinol. 2011;8(2):104-113.
10.
Connelly KJ, Boston BA, Pearce EN, et al. Congenital hypothyroidism caused by excess prenatal maternal iodine ingestion.J Pediatr. 2012;161(4):760-762.
11.
Brown RS, Bellisario RL, Botero D, et al. Incidence of transient congenital hypothyroidism due to maternal thyrotropin receptor-blocking antibodies in over one million babies.J Clin Endocrinol Metab. 1996;81(3):1147-1151.
12.
Bath SC, Steer CD, Golding J, Emmett P, Rayman MP. Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC).Գ. 2013;382(9889):331-337.
13.
Szinnai G. Clinical genetics of congenital hypothyroidism.Endocr Dev. 2014;26:60-78.
14.
Szinnai G. Genetics of normal and abnormal thyroid development in humans.Best Pract Res Clin Endocrinol Metab. 2014;28(2):133-150.
15.
LaFranchi SH. Approach to the diagnosis and treatment of neonatal hypothyroidism.J Clin Endocrinol Metab. 2011;96(10):2959-2967.
16.
Vulsma T, Gons MH, de Vijlder JJ. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis.N Engl J Med. 1989;321(1):13-16.
17.
Vigone MC, Caiulo S, Di Frenna M, et al. Evolution of thyroid function in preterm infants detected by screening for congenital hypothyroidism.J Pediatr. 2014;164(6):1296-1302.
18.
LaFranchi SH. Screening preterm infants for congenital hypothyroidism: better the second time around.J Pediatr. 2014;164(6):1259-1261.
19.
Grasberger H, Refetoff S. Genetic causes of congenital hypothyroidism due to dyshormonogenesis.Curr Opin Pediatr. 2011;23(4):421-428.
20.
Rabbiosi S, Vigone MC, Cortinovis F, et al. Congenital hypothyroidism with eutopic thyroid gland: analysis of clinical and biochemical features at diagnosis and after re-evaluation.J Clin Endocrinol Metab. 2013;98(4):1395-1402.
21.
Léger J, Olivieri A, Donaldson M, et al; ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE; Congenital Hypothyroidism Consensus Conference Group. European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism.J Clin Endocrinol Metab. 2014;99(2):363-384.
22.
Schoen EJ, Clapp W, To TT, Fireman BH. The key role of newborn thyroid scintigraphy with isotopic iodide (123I) in defining and managing congenital hypothyroidism.ʱ徱ٰ. 2004;114(6):e683-e688.
23.
Kumar J, Gordillo R, Kaskel FJ, Druschel CM, Woroniecki RP. Increased prevalence of renal and urinary tract anomalies in children with congenital hypothyroidism.J Pediatr. 2009;154(2):263-266.
24.
Selva KA, Harper A, Downs A, Blasco PA, Lafranchi SH. Neurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH.J Pediatr. 2005;147(6):775-780.
25.
Bongers-Schokking JJ, Resing WC, de Rijke YB, de Ridder MA, de Muinck Keizer-Schrama SM. Cognitive development in congenital hypothyroidism: is overtreatment a greater threat than undertreatment?J Clin Endocrinol Metab. 2013;98(11):4499-4506.
26.
Van Vliet G, Deladoëy J. Diagnosis, treatment and outcome of congenital hypothyroidism.Endocr Dev. 2014;26:50-59.
27.
de Vries L, Bulvik S, Phillip M. Chronic autoimmune thyroiditis in children and adolescents: at presentation and during long-term follow-up.Arch Dis Child. 2009;94(1):33-37.
28.
Gibson PA, Newton RW, Selby K, Price DA, Leyland K, Addison GM. Longitudinal study of thyroid function in Down’s syndrome in the first two decades.Arch Dis Child. 2005;90(6):574-578.
29.
Larizza D, Calcaterra V, Martinetti M. Autoimmune stigmata in Turner syndrome: when lacks an X chromosome.J Autoimmun. 2009;33(1):25-30.
30.
Karavanaki K, Kakleas K, Paschali E, et al. Screening for associated autoimmunity in children and adolescents with type 1 diabetes mellitus (T1DM).Horm Res. 2009;71(4):201-206.
31.
Sattar N, Lazare F, Kacer M, et al. Celiac disease in children, adolescents, and young adults with autoimmune thyroid disease.J Pediatr. 2011;158(2):272-275.e1.
32.
Uncu S, Yaylı S, Bahadır S, Okten A, Alpay K. Relevance of autoimmune thyroiditis in children and adolescents with vitiligo.Int J Dermatol. 2011;50(2):175-179.
33.
Delange F. The disorders induced by iodine deficiency.ճǾ. 1994;4(1):107-128.
34.
Kundra P, Burman KD. The effect of medications on thyroid function tests.Med Clin North Am. 2012;96(2):283-295.
35.
Hoang TD, Mai VQ, Clyde PW, Shakir MK. Over-the-counter-drug-induced thyroid disorders.Endocr Pract. 2013;19(2):268-274.
36.
Jonklaas J, Bianco AC, Bauer AJ, et al; American Thyroid Association Task Force on Thyroid Hormone Replacement. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement.ճǾ. 2014;24(12):1670-1751.
37.
Baranowski E, Högler W. An unusual presentation of acquired hypothyroidism: the Van Wyk–Grumbach syndrome.Eur J Endocrinol. 2012;166(3):537-542.
38.
Pacifico L, Anania C, Ferraro F, Andreoli GM, Chiesa C. ճǾ function in childhood obesity and metabolic comorbidity.Clin Chim Acta. 2012;413(3-4):396-405.
39.
World Health Organization (WHO). Goitre as a Determinant of the Prevalence and Severity of Iodine Deficiency Disorders in Populations. Geneva, Switzerland: WHO; 2014.
40.
Lavard L, Ranløv I, Perrild H, Andersen O, Jacobsen BB. Incidence of juvenile thyrotoxicosis in Denmark, 1982-1988: a nationwide study.Eur J Endocrinol. 1994;130(6):565-568.
41.
Foley TP Jr. Thyrotoxicosis in childhood.Pediatr Ann. 1992;21(1):43-46, 48-49.
42.
Rivkees SA, Mattison DR. Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use.Int J Pediatr Endocrinol. 2009;2009:132041.
43.
Williamson S, Greene SA. Incidence of thyrotoxicosis in childhood: a national population based study in the UK and Ireland.Clin Endocrinol (Oxf). 2010;72(3):358-363.
44.
Hemminki K, Li X, Sundquist J, Sundquist K. The epidemiology of Graves’ disease: evidence of a genetic and an environmental contribution.J Autoimmun. 2010;34(3):J307-J313.
45.
Aversa T, Lombardo F, Corrias A, Salerno M, De Luca F, Wasniewska M. In young patients with Turner or Down syndrome, Graves' disease presentation is often preceded by Hashimoto's thyroiditis.ճǾ. 2014;24(4):744-747.
46.
Bahn RS, Burch HB, Cooper DS, et al; American Thyroid Association; American Association of Clinical Endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists [published correction appears in Endocr Pract. 2013;19(2):384].Endocr Pract. 2011;17(3):456-520.
47.
Onigata K, Szinnai G. Resistance to thyroid hormone.Endocr Dev. 2014;26:118-129.
48.
Baskaran C, Misra M, Levitsky LL. Diagnosis of pediatric hyperthyroidism: technetium 99 uptake vs thyroid stimulating immunoglobulins.ճǾ. 2015;25(1):37-42.
49.
Bauer AJ. Approach to the pediatric patient with Graves’ disease: when is definitive therapy warranted?J Clin Endocrinol Metab. 2011;96(3):580-588.
50.
Morshed SA, Davies TF. Graves' disease mechanisms: the role of stimulating, blocking, and cleavage region TSH receptor antibodies.Horm Metab Res. 2015;47(10):727-734.
51.
Zimmerman D. Fetal and neonatal hyperthyroidism.ճǾ. 1999;9(7):727-733.
52.
Sims EK, Eugster EA, Nebesio TD. Detours on the road to diagnosis of Graves disease.Clin Pediatr (Phila). 2012;51(2):160-164.
53.
Goldstein SM, Katowitz WR, Moshang T, Katowitz JA. Pediatric thyroid–associated orbitopathy: the Children's Hospital of Philadelphia experience and literature review.ճǾ. 2008;18(9):997-999.
54.
Robinson DC, Hall R, Munro DS. Graves’s disease, an unusual complication: raised intracranial pressure due to premature fusion of skull sutures.Arch Dis Child. 1969;44(234):252-257.
55.
Park RW, Frasier SD. Hyperthyroidism under 2 years of age.Am J Dis Child. 1970;120(2):157-159.
56.
Rivkees SA, Szarfman A. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children.J Clin Endocrinol Metab. 2010;95(7):3260-3267.
57.
Rivkees SA. 63 years and 715 days to the “boxed warning”: unmasking of the propylthiouracil problem.Int J Pediatr Endocrinol. 2010;2010:658267.
58.
Ohye H, Minagawa A, Noh JY, et al. Antithyroid drug treatment for Graves' disease in children: a long-term retrospective study at a single institution.ճǾ. 2014;24(2):200-207.
59.
Rivkees SA, Stephenson K, Dinauer C. Adverse events associated with methimazole therapy of Graves' disease in children.Int J Pediatr Endocrinol. 2010;2010:176970.
60.
Siegel DA, King J, Tai E, Buchanan N, Ajani UA, Li J. Cancer incidence rates and trends among children and adolescents in the United States, 2001-2009.ʱ徱ٰ. 2014;134(4):e945-e955.
61.
Fushiki S. Radiation hazards in children—lessons from Chernobyl, Three Mile Island and Fukushima.Brain Dev. 2013;35(3):220-227.
62.
Schonfeld SJ, Lee C, Berrington de González A. Medical exposure to radiation and thyroid cancer.Clin Oncol (R Coll Radiol). 2011;23(4):244-250.
63.
Veiga LH, Lubin JH, Anderson H, et al. A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer [published correction appears in Radiat Res. 2013;180(6):e41].Radiat Res. 2012;178(4):365-376.
64.
Mathews JD, Forsythe AV, Brady Z, et al. Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians.Ѵ. 2013;346:f2360.
65.
Kambalapalli M, Gupta A, Prasad UR, Francis GL. Ultrasound characteristics of the thyroid in children and adolescents with goiter: a single center experience.ճǾ. 2015;25(2):176-182.
66.
Corrias A, Cassio A, Weber G, et al; Study Group for Thyroid Diseases of Italian Society for Pediatric Endocrinology and Diabetology (SIEDP/ISPED). ճǾ nodules and cancer in children and adolescents affected by autoimmune thyroiditis.Arch Pediatr Adolesc Med. 2008;162(6):526-531.
67.
Wells SA Jr, Asa SL, Dralle H, et al; American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.ճǾ. 2015;25(6):567-610.
68.
Francis GL, Waguespack SG, Bauer AJ, et al; American Thyroid Association Guidelines Task Force. Management guidelines for children with thyroid nodules and differentiated thyroid cancer.ճǾ. 2015;25(7):716-759.
69.
Bauer AJ. Clinical behavior and genetics of nonsyndromic, familial nonmedullary thyroid cancer.Front Horm Res. 2013;41:141-148.
70.
Gupta A, Ly S, Castroneves LA, et al. How are childhood thyroid nodules discovered: opportunities for improving early detection.J Pediatr. 2014;164(3):658-660.
71.
Mussa A, De Andrea M, Motta M, Mormile A, Palestini N, Corrias A. Predictors of malignancy in children with thyroid nodules.J Pediatr. 2015;167(4):886-892.e1.
72.
Gupta A, Ly S, Castroneves LA, et al. A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults.J Clin Endocrinol Metab. 2013;98(8):3238-3245.
73.
Hogan AR, Zhuge Y, Perez EA, Koniaris LG, Lew JI, Sola JE. Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients.J Surg Res. 2009;156(1):167-172.
74.
Carty SE, Cooper DS, Doherty GM, et al; American Thyroid Association Surgery Working Group; American Association of Endocrine Surgeons; American Academy of Otolaryngology-Head and Neck Surgery; American Head and Neck Society. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer.ճǾ. 2009;19(11):1153-1158.
75.
Pawelczak M, David R, Franklin B, Kessler M, Lam L, Shah B. Outcomes of children and adolescents with well-differentiated thyroid carcinoma and pulmonary metastases following 131I treatment: a systematic review.ճǾ. 2010;20(10):1095-1101.
76.
Brauckhoff M, Machens A, Lorenz K, Bjøro T, Varhaug JE, Dralle H. Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective.Ann Surg. 2014;259(4):800-806.
77.
Eng C. PTEN hamartoma tumor syndrome (PHTS). In: Pagon RA, Adam MP, Ardinger HH, et al, eds. ұԱ𱹾ɲ. Seattle, WA. . Accessed May 3, 2016.
78.
Jasperson KW, Burt RW. APC-associated polyposis conditions. In: Pagon RA, Adam MP, Ardinger HH, et al, eds. ұԱ𱹾ɲ. Seattle, WA. . Accessed May 3, 2016.
79.
Stratakis CA, Salpea P, Raygada M. Carney complex. In: Pagon RA, Adam MP, Ardinger HH, et al, eds. ұԱ𱹾ɲ. Seattle, WA. . Accessed May 3, 2016.
80.
Wray CJ, Rich TA, Waguespack SG, Lee JE, Perrier ND, Evans DB. Failure to recognize multiple endocrine neoplasia 2B: more common than we think?Ann Surg Oncol. 2008;15(1):293-301.
81.
Marquard J, Eng C. Multiple endocrine neoplasia type 2. In: Pagon RA, Adam MP, Ardinger HH, et al, eds. ұԱ𱹾ɲ. Seattle, WA. . Accessed May 3, 2016.
82.
Yeh MW, Bauer AJ, Bernet VA, et al; American Thyroid Association Surgical Affairs Committee Writing Task Force. American Thyroid Association statement on preoperative imaging for thyroid cancer surgery.ճǾ. 2015;25(1):3-14.
83.
Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis.Acta Cytol. 2012;56(4):333-339.
Views 15,062
Review
ٴDz2016

Thyroid Disorders in Children and Adolescents: A Review

Author Affiliations
  • 1The Thyroid Center, Division of Endocrinology and Diabetes, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  • 2Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia
JAMA Pediatr. 2016;170(10):1008-1019. doi:10.1001/jamapediatrics.2016.0486
Abstract

Importance Normal thyroid gland function is critical for early neurocognitive development, as well as for growth and development throughout childhood and adolescence. Thyroid disorders are common, and attention to physical examination findings, combined with selected laboratory and radiologic tools, aids in the early diagnosis and treatment.

Objective To provide a practical review of the presentation, evaluation, and treatment of thyroid disorders commonly encountered in a primary care practice.

Evidence Review We performed a literature review using the PubMed database. Results focused on reviews and articles published from January 1, 2010, through December 31, 2015. Articles published earlier than 2010 were included when appropriate for historical perspective. Our review emphasized evidence-based management practices for the clinician, as well as consensus statements and guidelines. A total of 479 articles for critical review were selected based on their relevance to the incidence, pathophysiology, laboratory evaluation, radiological assessment, and treatment of hypothyroidism, hyperthyroidism, thyroid nodules, and thyroid cancer in children and adolescents. Eighty-three publications were selected for inclusion in this article based on their relevance to these topics.

Findings The primary care physician is often the first health care professional responsible for initiating the evaluation of a thyroid disorder in children and adolescents. Patients may be referred secondary to an abnormal newborn screening, self-referred after a caregiver raises concern, or identified to be at risk of a thyroid disorder based on findings from a routine well-child visit. Irrespective of the path of referral, knowledge of the signs and symptoms of hypothyroidism, hyperthyroidism, and thyroid nodules, as well as the general approach to evaluation and management, will help the primary care physician complete an initial assessment and determine which patients would benefit from referral to a pediatric endocrinologist.

Conclusions and Relevance Early identification and treatment of thyroid disease in children and adolescents is critical to optimize growth and development. The primary care physician plays a critical role in identifying patients at risk. An understanding of risk factors, clinical signs and symptoms, and interpretation of screening laboratories ensures an efficient and accurate diagnosis of these common disorders. Regular communication between the primary care physician and the subspecialist is critical to optimize outcome because the majority of patients with thyroid disorders will require long-term to lifelong medical therapy and/or surveillance.

×